Your browser doesn't support javascript.
loading
Chimeric antigen receptor T cells engineered to secrete CD40 agonist antibodies enhance antitumor efficacy.
Zhang, Yajun; Wang, Pei; Wang, Tengjiao; Fang, Yuan; Ding, Yongmei; Qian, Qijun.
Affiliation
  • Zhang Y; Department of Biotherapy, Eastern Hepatobiliary Surgery Hospital, Navy Medical University, Shanghai, 201805, China.
  • Wang P; Shanghai Engineering Research Center for Cell Therapy, Shanghai, 201805, China.
  • Wang T; Department of Bioinformatics, Institute of Translational Medicine, Navy Medical University, Shanghai, 201805, China.
  • Fang Y; Shanghai Engineering Research Center for Cell Therapy, Shanghai, 201805, China.
  • Ding Y; College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, 310018, Zhejiang, China.
  • Qian Q; Department of Biotherapy, Eastern Hepatobiliary Surgery Hospital, Navy Medical University, Shanghai, 201805, China.
J Transl Med ; 19(1): 82, 2021 02 18.
Article in En | MEDLINE | ID: mdl-33602263
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Chimeric Antigen Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: J Transl Med Year: 2021 Document type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Chimeric Antigen Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: J Transl Med Year: 2021 Document type: Article Affiliation country: China